Testing effectiveness (Phase 2)Study completedNCT04776239
What this trial is testing
Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD)
Who this might be right for
Diabetes MellitusIschemic Heart Disease
Joshua M Hare 26